Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study seeks better way to spot hidden immune disorder in ICU

NCT ID NCT07343037

First seen Jan 20, 2026 · Last updated Apr 30, 2026 · Updated 14 times

Summary

This study looks at how well a scoring tool called the HScore can diagnose hemophagocytic lymphohistiocytosis (HLH) in intensive care patients who also have liver failure or cirrhosis. Researchers will review medical records of 100 adults admitted to one hospital over ten years. The goal is to find the best markers for this rare but serious immune condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRRHOSIS, LIVER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Médecine intensive - Réanimation - CHU de Strasbourg - France

    RECRUITING

    Strasbourg, 67091, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.